Kwang Dong Pharmaceutical Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was KRW 817.48 million compared to KRW 791.42 million a year ago. Net income was KRW 8,940.88 million compared to KRW 30,515.25 million a year ago. Basic earnings per share from continuing operations was KRW 218 compared to KRW 743 a year ago. Diluted earnings per share from continuing operations was KRW 217 compared to KRW 742 a year ago. Basic earnings per share was KRW 218 compared to KRW 743 a year ago. Diluted earnings per share was KRW 217 compared to KRW 742 a year ago.
For the nine months, sales was KRW 1,810.97 million compared to KRW 2,543.67 million a year ago. Net income was KRW 17,431.9 million compared to KRW 52,159.86 million a year ago. Basic earnings per share from continuing operations was KRW 424 compared to KRW 1,293 a year ago. Diluted earnings per share from continuing operations was KRW 424 compared to KRW 1,293 a year ago. Basic earnings per share was KRW 424 compared to KRW 1,293 a year ago.